HEADER VIRAL PROTEIN/INHIBITOR 30-MAY-07 2Q3I TITLE CRYSTAL STRUCTURE OF THE D10-P3/IQN17 COMPLEX: A D-PEPTIDE INHIBITOR TITLE 2 OF HIV-1 ENTRY BOUND TO THE GP41 COILED-COIL POCKET COMPND MOL_ID: 1; COMPND 2 MOLECULE: FUSION PROTEIN BETWEEN THE COILED-COIL POCKET OF HIV GP41 COMPND 3 AND GCN4-PIQI; COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: D-PEPTIDE; COMPND 8 CHAIN: D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: PEPTIDE SYNTHESIS. GCN4-HIV GP41 FUSION, CALLED SOURCE 4 IQN17. THE SEQUENCE NATURALLY OCCURS IN SACCHAROMYCES CEREVISIAE AND SOURCE 5 HUMAN IMMUNODEFICIENCY VIRUS; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 OTHER_DETAILS: PEPTIDE SYNTHESIS. D-PEPTIDE FOUND BY SCREENING. KEYWDS ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR V.N.MALASHKEVICH,D.M.ECKERT,L.H.HONG,P.A.CARR,P.S.KIM REVDAT 5 15-NOV-23 2Q3I 1 REMARK REVDAT 4 30-AUG-23 2Q3I 1 REMARK LINK REVDAT 3 13-JUL-11 2Q3I 1 VERSN REVDAT 2 24-FEB-09 2Q3I 1 VERSN REVDAT 1 12-JUN-07 2Q3I 0 JRNL AUTH D.M.ECKERT,V.N.MALASHKEVICH,L.H.HONG,P.A.CARR,P.S.KIM JRNL TITL INHIBITING HIV ENTRY: DISCOVERY OF D-PEPTIDE INHIBITORS THAT JRNL TITL 2 TARGET THE GP41 COILED-COIL POCKET JRNL REF CELL(CAMBRIDGE,MASS.) V. 99 103 1999 JRNL REFN ISSN 0092-8674 JRNL PMID 10520998 JRNL DOI 10.1016/S0092-8674(00)80066-5 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.M.ECKERT,V.N.MALASHKEVICH,P.S.KIM REMARK 1 TITL CRYSTAL STRUCTURE OF GCN4-PIQI, A TRIMERIC COILED-COIL WITH REMARK 1 TITL 2 BURIED POLAR RESIDUES. REMARK 1 REF J.MOL.BIOL. V. 284 859 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.C.CHAN,D.FASS,J.M.BERGER,P.S.KIM REMARK 1 TITL CORE STRUCTURE OF GP41 FROM THE HIV ENVELOPE GLYCOPROTEIN REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 89 263 1997 REMARK 1 REFN ISSN 0092-8674 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 16309 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1639 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.59 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2188 REMARK 3 BIN R VALUE (WORKING SET) : 0.3450 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 219 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 509 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 154 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.60000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : -13.44000 REMARK 3 B12 (A**2) : 0.56100 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.09 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.12 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.310 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 15.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.960 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.500 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.850 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.680 ; 3.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.42 REMARK 3 BSOL : 111.5 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP_D.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARA REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Q3I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1000043102. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16309 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.10 REMARK 200 R MERGE FOR SHELL (I) : 0.23500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1CZQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% ETHANOL, 1.5 M SODIUM CHLORIDE, PH REMARK 280 7.5, VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS TRIMER FORMED AROUND THE REMARK 300 CRYSTALLOGRAPHIC 3-FOLD AXIS REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 8800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -86.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 50.70200 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 25.35100 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 43.90922 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CL CL A 201 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 233 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 269 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 281 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 299 LIES ON A SPECIAL POSITION. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF D-PEPTIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CZQ RELATED DB: PDB DBREF 2Q3I A 28 45 UNP A3F986 A3F986_9HIV1 566 583 DBREF 2Q3I D 0 16 PDB 2Q3I 2Q3I 0 16 SEQRES 1 A 46 ACE ARG MET LYS GLN ILE GLU ASP LYS ILE GLU GLU ILE SEQRES 2 A 46 GLU SER LYS GLN LYS LYS ILE GLU ASN GLU ILE ALA ARG SEQRES 3 A 46 ILE LYS LYS LEU LEU GLN LEU THR VAL TRP GLY ILE LYS SEQRES 4 A 46 GLN LEU GLN ALA ARG ILE LEU SEQRES 1 D 17 ACE GLY DAL DCY GLY DLE GLY DGN DGL DGL DTR DPN DTR SEQRES 2 D 17 DLE DCY DAL DAL HET ACE A 0 3 HET ACE D 0 3 HET DAL D 2 5 HET DCY D 3 6 HET DLE D 5 8 HET DGN D 7 9 HET DGL D 8 9 HET DGL D 9 9 HET DTR D 10 14 HET DPN D 11 11 HET DTR D 12 14 HET DLE D 13 8 HET DCY D 14 6 HET DAL D 15 5 HET DAL D 16 6 HET CL A 201 1 HETNAM ACE ACETYL GROUP HETNAM DAL D-ALANINE HETNAM DCY D-CYSTEINE HETNAM DLE D-LEUCINE HETNAM DGN D-GLUTAMINE HETNAM DGL D-GLUTAMIC ACID HETNAM DTR D-TRYPTOPHAN HETNAM DPN D-PHENYLALANINE HETNAM CL CHLORIDE ION FORMUL 1 ACE 2(C2 H4 O) FORMUL 2 DAL 3(C3 H7 N O2) FORMUL 2 DCY 2(C3 H7 N O2 S) FORMUL 2 DLE 2(C6 H13 N O2) FORMUL 2 DGN C5 H10 N2 O3 FORMUL 2 DGL 2(C5 H9 N O4) FORMUL 2 DTR 2(C11 H12 N2 O2) FORMUL 2 DPN C9 H11 N O2 FORMUL 3 CL CL 1- FORMUL 4 HOH *154(H2 O) HELIX 1 1 ARG A 1 LEU A 45 1 45 HELIX 2 2 GLY D 4 DGL D 9 5 6 HELIX 3 3 DTR D 10 DAL D 16 1 7 SSBOND 1 DCY D 3 DCY D 14 1555 1555 2.66 LINK C ACE A 0 N ARG A 1 1555 1555 1.32 LINK C ACE D 0 N GLY D 1 1555 1555 1.33 LINK C GLY D 1 N DAL D 2 1555 1555 1.32 LINK C DAL D 2 N DCY D 3 1555 1555 1.33 LINK C DCY D 3 N GLY D 4 1555 1555 1.33 LINK C GLY D 4 N DLE D 5 1555 1555 1.34 LINK C DLE D 5 N GLY D 6 1555 1555 1.33 LINK C GLY D 6 N DGN D 7 1555 1555 1.33 LINK C DGN D 7 N DGL D 8 1555 1555 1.33 LINK C DGL D 8 N DGL D 9 1555 1555 1.33 LINK C DGL D 9 N DTR D 10 1555 1555 1.32 LINK C DTR D 10 N DPN D 11 1555 1555 1.33 LINK C DPN D 11 N DTR D 12 1555 1555 1.34 LINK C DTR D 12 N DLE D 13 1555 1555 1.33 LINK C DLE D 13 N DCY D 14 1555 1555 1.35 LINK C DCY D 14 N DAL D 15 1555 1555 1.33 LINK C DAL D 15 N DAL D 16 1555 1555 1.34 SITE 1 AC1 1 GLN A 16 SITE 1 AC2 32 ARG A 1 LYS A 3 GLU A 6 ASP A 7 SITE 2 AC2 32 GLU A 10 LEU A 32 VAL A 34 TRP A 35 SITE 3 AC2 32 LYS A 38 GLN A 41 HOH A 220 HOH A 249 SITE 4 AC2 32 HOH D 18 HOH D 20 HOH D 21 HOH D 22 SITE 5 AC2 32 HOH D 23 HOH D 24 HOH D 25 HOH D 26 SITE 6 AC2 32 HOH D 28 HOH D 29 HOH D 30 HOH D 31 SITE 7 AC2 32 HOH D 32 HOH D 33 HOH D 42 HOH D 43 SITE 8 AC2 32 HOH D 45 HOH D 47 HOH D 49 HOH D 61 CRYST1 50.702 50.702 67.858 90.00 90.00 120.00 P 3 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019723 0.011387 0.000000 0.00000 SCALE2 0.000000 0.022774 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014737 0.00000 HETATM 1 C ACE A 0 18.821 9.402 65.154 1.00 27.28 C HETATM 2 O ACE A 0 18.876 8.915 64.015 1.00 27.38 O HETATM 3 CH3 ACE A 0 18.551 8.528 66.343 1.00 28.05 C